01-1461. National Institute on Drug Abuse; Notice of Closed Meetings  

  • Start Preamble Start Printed Page 4846

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, “Novel Drug Delivery System for the Mouse”.

    Date: January 11, 2001.

    Time: 11 a.m. to 1 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).

    Contact Person: Richard C. Harrison, Chief, Contract Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, 301-435-1437.

    This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

    Name of Committee: National Institute on Drug Abuse, Special Emphasis Panel, “Chemical Libraries for Drug Development”.

    Date: January 18, 2001.

    Time: 1 p.m. to 3 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).

    Contact Person: Eric Zatman, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, 301-435-1438.

    This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, “Development of Science Education Materials or Programs”.

    Date: January 31, 2001.

    Time: 9 a.m. to 5 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.

    Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, 301-435-1439.

    Start Signature

    (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS)

    Dated: January 10, 2001.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 01-1461 Filed 1-17-01; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
1/11/2001
Published:
01/18/2001
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
01-1461
Dates:
January 11, 2001.
Pages:
4846-4846 (1 pages)
PDF File:
01-1461.pdf